How can Big Pharma and Europe unite to speed up vaccinations?

Question

Accepted Answer

Call for Unity Between European Nations and Big Pharma to Accelerate Vaccinations

A significant call has been made for European nations and major pharmaceutical companies to collaborate and expedite coronavirus inoculations. This appeal comes amidst growing pressure for a more equitable distribution of vaccine supplies to less affluent countries, as current rollouts in Europe have been hampered by supply shortages and diplomatic disputes.
Addressing Supply and Production Capacity Tensions

The World Health Organisation (WHO) Europe director, Hans Kluge, emphasized the need for a unified approach to accelerate vaccinations. He specifically highlighted that competing pharmaceutical companies must collectively increase production capacity to meet the escalating demand. This call addresses the ongoing tension between firms and European Union officials regarding production capabilities, a key factor in the continent's slower vaccine rollout.
Equitable Distribution and Dose Sharing

Pressure is mounting for wealthier nations to adopt a more equitable allocation strategy for vaccine supplies. While the milestone of 100 million administered doses has been reached globally, a substantial 65 per cent were distributed in high-income countries. Rich countries, many of whom have secured doses significantly exceeding their needs—ranging from four to nine times their population—are being urged to donate surplus vaccines once their most vulnerable populations have been inoculated.
Advancements in Vaccine Technology and Global Rollout

New vaccine developments offer potential logistical advantages. Johnson & Johnson has applied for emergency authorisation in the United States for its single-shot vaccine, which does not require two doses or ultra-cold storage, unlike some existing options. While trials indicate this vaccine may be less effective against certain variants, its ease of use could significantly boost global supply if approved. Simultaneously, other nations are diversifying their vaccine portfolios, with Serbia achieving Europe's fastest vaccination rate by opting for China's Sinopharm vaccine, and Iran receiving its first shipment of Russia's Sputnik V.

Reading history

Hide →

This history is cleared when the page is closed.

How can Big Pharma and Europe unite to speed up vaccinations?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends